Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
We think deeply about this, and we care a lot about it
GLP-1 drugs (glucagon-like peptide-1 receptor agonists) are medications developed to treat both type 2 diabetes and obesity by correcting hormonal imbalance - stimulating insulin release and suppressing excess glucagon -to bring blood sugar back under control
The dosage of tirzepatide was gradually increased every 4 weeks until the assigned dose was reached
With disease activity categorized on a scale of 0 to 3 (remission to severe), the group averages changed by -0.03 points for those using GLP-1 agonists versus +0.21 for non-users ( P =0.03)
.jpg)
US$ 22.76
US$ 22.91
US$ 25.58
